Peinert S - Search Results

1

Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma.

Thompson PA, Prince HM, Seymour JF, Ritchie D, Stokes K, Burbury K, Wolf M, Peinert S, Joyce T, Harrison SJ. Thompson PA, et al. Among authors: peinert s. Bone Marrow Transplant. 2011 May;46(5):764-5. doi: 10.1038/bmt.2010.180. Epub 2010 Aug 2. Bone Marrow Transplant. 2011. PMID: 20676149 No abstract available.

2

The development of novel immunotherapeutic approaches in multiple myeloma.

Peinert S, Prince HM, Harrison S. Peinert S, et al. Leuk Lymphoma. 2008 Apr;49(4):652-4. doi: 10.1080/10428190802007742. Leuk Lymphoma. 2008. PMID: 18398729 Review. No abstract available.

3

Indolent lymphomas other than follicular and marginal zone lymphomas.

Peinert S, Seymour JF. Peinert S, et al. Hematol Oncol Clin North Am. 2008 Oct;22(5):903-40, viii. doi: 10.1016/j.hoc.2008.07.005. Hematol Oncol Clin North Am. 2008. PMID: 18954743 Review.

4

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen.

Peinert S, Prince HM, Guru PM, Kershaw MH, Smyth MJ, Trapani JA, Gambell P, Harrison S, Scott AM, Smyth FE, Darcy PK, Tainton K, Neeson P, Ritchie DS, Hönemann D. Peinert S, et al. Gene Ther. 2010 May;17(5):678-86. doi: 10.1038/gt.2010.21. Epub 2010 Mar 4. Gene Ther. 2010. PMID: 20200563

5

Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma.

Peinert S, Kamel S, Seymour JF, Prince HM. Peinert S, et al. Leuk Lymphoma. 2009 Feb;50(2):303-5. doi: 10.1080/10428190802617805. Leuk Lymphoma. 2009. PMID: 19197721 No abstract available.

6

Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia.

Peinert S, Seymour JF. Peinert S, et al. Leuk Lymphoma. 2010 Oct;51(10):1767-70. doi: 10.3109/10428194.2010.509455. Leuk Lymphoma. 2010. PMID: 20919859 No abstract available.

7

Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia.

Peinert S, Tam CS, Prince HM, Scarlett J, Wolf MM, Januszewicz EH, Westerman D, Seymour JF. Peinert S, et al. Leuk Lymphoma. 2010 Dec;51(12):2188-97. doi: 10.3109/10428194.2010.524326. Epub 2010 Oct 12. Leuk Lymphoma. 2010. PMID: 20939696

8

Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?

Peinert S, Carney D, Prince HM, Januszewicz EH, Seymour JF. Peinert S, et al. Br J Haematol. 2009 Sep;146(6):685-6. doi: 10.1111/j.1365-2141.2009.07806.x. Epub 2009 Jul 23. Br J Haematol. 2009. PMID: 19638019 Free article. No abstract available.

9

Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype.

Neeson P, Shin A, Tainton KM, Guru P, Prince HM, Harrison SJ, Peinert S, Smyth MJ, Trapani JA, Kershaw MH, Darcy PK, Ritchie DS. Neeson P, et al. Among authors: peinert s. Gene Ther. 2010 Sep;17(9):1105-16. doi: 10.1038/gt.2010.59. Epub 2010 Apr 29. Gene Ther. 2010. PMID: 20428216

10

Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future.

Peinert S, Kershaw MH, Prince HM. Peinert S, et al. Immunotherapy. 2009 Nov;1(6):905-12. doi: 10.2217/imt.09.69. Immunotherapy. 2009. PMID: 20635906 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters